Mcintyre Freedman & Flynn Investment Advisers Inc Novartis Ag Call Options Transaction History
Mcintyre Freedman & Flynn Investment Advisers Inc
- $139 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.33 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$811 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$810 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$650 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...